Acenocoumarol PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Acenocoumarol PCD pharma franchise company offering 4 WHO-GMP certified formulations available in Tablets. We provide monopoly-based distribution rights to pharma entrepreneurs and distributors across India, backed by DCGI-approved quality and a reliable supply chain.
What is Acenocoumarol?
Acenocoumarol is an oral vitamin K antagonist anticoagulant that reduces the production of clotting factors to prevent and treat blood clots. It is a prescription-only medicine that requires regular blood monitoring and must be used strictly under qualified medical supervision. Read the compound profile on PubChem.
Available Acenocoumarol Formulations
Cafoli Lifecare offers 4 Acenocoumarol formulations for franchise partners. Available forms: Tablets. Every batch is manufactured at WHO-GMP certified facilities and supplied with full regulatory documentation. Pricing is shared on request.
Therapeutic Applications
Acenocoumarol is used to prevent and treat venous thromboembolism and to reduce clot risk in atrial fibrillation and in patients with prosthetic heart valves. It is prescribed mainly by cardiologists and general physicians.
Why Acenocoumarol is a High-Potential Molecule for Distributors
Long-term anticoagulation involves regular monitoring and continuous therapy, so Acenocoumarol generates steady, recurring demand among cardiac and thrombosis patients under chronic care.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved products, attractive promotional inputs and dedicated marketing support to a growing network of 1000+ franchise partners across India. Our focus on quality and on-time supply makes us a preferred Acenocoumarol franchise partner.
References
- PubChem: Acenocoumarol
- PubMed research on Acenocoumarol
Our formulations of Acenocoumarol find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: